John R. Lurain

No ORCID on file · 1 paper in corpus · active 2017

Study types

  • article 1
article 2017
·doi:10.1080/15384047.2017.1281496

The purpose of this study was to test the effect of MK2206, an allosteric inhibitor of AKT, on the growth and invasion of patient-derived xenografts (PDX) of endometrial cancer. Three PDX lines, USC1 (uterine serous), EEC2 (endometrioid gra…